Disease-modifying therapy

2 papers1 finding

1 lab in 1 country

Funder: Universitätsklinikum Köln

Humans2

Associations

1

Age

downin humans1

1 study

Age is associated with disease-modifying therapy in humans (42.6% and 60.9% vs 76.7%).
“proportion of individuals with current use of disease modifying therapy was lower (42.6%, 60.9% and 76.7%, respectively)”
Humansmultiple sclerosisn = 40,428
Persons with multiple sclerosis older than 55 years: an analysis from the German MS registry
Journal of neurologyMar 22, 2024

Latest

1 in 12 months

Zhurnal Nevrologii I Psikhiatrii Imeni S.S KorsakovaMay 14

Age-related aspects of multiple sclerosis

Cohort study in peopleMultiple sclerosis

Journal of NeurologyMar 22

Persons with multiple sclerosis older than 55 years: an analysis from the German MS registry

Cohort study of 40,428 peopleMultiple sclerosis